IMPORTANCE OF PRIMARY SITE IN ASSESSING CHEMOTHERAPY RESPONSE AND 7-YEAR SURVIVAL-DATA IN ADVANCED SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK TREATED WITH INITIAL COMBINATION CHEMOTHERAPY WITHOUT CISPLATIN

被引：39

作者：

HILL, BT

PRICE, LA

MACRAE, K

机构：

[1] IMPERIAL CANC RES FUND LABS, LONDON WC2A 3PX, ENGLAND

[2] ROYAL MARSDEN HOSP, HEAD & NECK UNIT, LONDON, ENGLAND

[3] CHARING CROSS & WESTMINSTER MED SCH, DEPT STAT, LONDON, ENGLAND

来源：

关键词：

D O I：

10.1200/JCO.1986.4.9.1340

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1340 / 1347

页数：8

共 42 条

[1]

AMER MH, 1979, CANCER, V43, P2202, DOI 10.1002/1097-0142(197906)43:6<2202::AID-CNCR2820430607>3.0.CO

[2]

2-J

AMREIN, PC ;

WIETZMAN, SA .

[4]

BROWN AW, 1980, CANCER-AM CANCER SOC, V45, P2830, DOI 10.1002/1097-0142(19800601)45:11<2830::AID-CNCR2820451119>3.0.CO

[5]

2-#

[6]

COX DR, 1972, J R STAT SOC B, V34, P187

[7]

ELIAS EG, 1979, CANCER, V43, P1025, DOI 10.1002/1097-0142(197903)43:3<1025::AID-CNCR2820430336>3.0.CO

[8]

2-#

[9]

ENSLEY JF, 1984, CANCER, V54, P811, DOI 10.1002/1097-0142(19840901)54:5<811::AID-CNCR2820540508>3.0.CO

[10]

2-E